CONMED Corp (CNMD) earnings date, results and what the price requires
NYSE · SEC CIK 0000816956 · SEC filings checked Oct 16, 2026
Next report
Nov 4, 2026
Estimated from reporting history (98-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$47.14
Polygon.io daily close, Oct 15, 2026. End of day, not live.
Trailing diluted EPS
—
Needs four consecutive reported quarters.
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $343.5M | $23.1M | $0.77 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $337.9M | $2.9M | $0.09 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $342.3M | $21.4M | $0.69 | Filing |
| Dec 31, 2024 | Feb 5, 2025 | $345.9M | $33.7M | $1.09 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $316.7M | $49.0M | $1.57 | Filing |
| Jun 30, 2024 | Jul 31, 2024 | $332.1M | $30.0M | $0.96 | Filing |
| Mar 31, 2024 | Apr 24, 2024 | $312.3M | $19.7M | $0.63 | Filing |
| Dec 31, 2023 | Jan 31, 2024 | $327.0M | $33.1M | $1.05 | Filing |
What would CONMED Corp have to report for its valuation to change?
Four consecutive reported quarters of diluted EPS are not available in SEC filings. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.